LHC Group, Inc. (NASDAQ:LHCG) – William Blair lifted their Q2 2019 earnings estimates for LHC Group in a research note issued on Monday, April 8th, Zacks Investment Research reports. William Blair analyst M. Larew now expects that the health services provider will earn $1.02 per share for the quarter, up from their previous forecast of $1.01. William Blair also issued estimates for LHC Group’s FY2020 earnings at $4.70 EPS.
A number of other research analysts also recently issued reports on LHCG. BidaskClub downgraded LHC Group from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 28th. Craig Hallum upped their price target on LHC Group from $93.00 to $114.00 and gave the company a “hold” rating in a report on Friday, March 1st. They noted that the move was a valuation call. SunTrust Banks upped their price target on LHC Group to $130.00 and gave the company a “buy” rating in a report on Friday, March 1st. Robert W. Baird upped their price target on LHC Group from $98.00 to $120.00 and gave the company a “neutral” rating in a report on Monday, March 4th. Finally, Barclays upped their price target on LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Thursday, March 21st. One analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $113.25.
LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.03. LHC Group had a return on equity of 8.40% and a net margin of 3.50%. The business had revenue of $509.80 million for the quarter, compared to the consensus estimate of $522.21 million. During the same period in the previous year, the company posted $0.62 earnings per share. The company’s revenue for the quarter was up 75.1% compared to the same quarter last year.
Hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC increased its position in LHC Group by 790.0% in the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock worth $30,000 after buying an additional 237 shares in the last quarter. Sageworth Trust Co purchased a new stake in LHC Group in the first quarter worth about $36,000. Financial Gravity Companies Inc. purchased a new stake in LHC Group in the fourth quarter worth about $49,000. Quadrant Capital Group LLC increased its position in LHC Group by 1,045.7% in the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after buying an additional 481 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new stake in LHC Group in the first quarter worth about $68,000. 92.98% of the stock is currently owned by institutional investors.
In other LHC Group news, CEO Keith G. Myers sold 11,558 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $108.83, for a total value of $1,257,857.14. Following the transaction, the chief executive officer now owns 96,315 shares of the company’s stock, valued at $10,481,961.45. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Joshua L. Proffitt sold 11,003 shares of the stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $107.36, for a total value of $1,181,282.08. Following the completion of the transaction, the executive vice president now directly owns 66,980 shares in the company, valued at approximately $7,190,972.80. The disclosure for this sale can be found here. In the last three months, insiders sold 117,876 shares of company stock worth $12,762,540. 6.80% of the stock is owned by corporate insiders.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
See Also: What is range trading?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.